South Korea, Samsung, Hyundai + Neuromorphic Chips, page-418

First 418 Last

Share
Profile

Follow
Tiptoe18

509 Posts.

99

29/04/21

14:00

Post #: 52813923
Share

Originally posted by Realinfo: ↑

In the mid 80’s, I visited the Hanover Fair in what was then West Germany. I spotted an interesting bit of materials handling kit and purchased the smallest version available.
Back in Oz, we set about making a better mouse trap.
We believed the weakness in the German product was its control system. We wanted ours to be superior in a standalone environment, but more importantly, to be easy to interface seamlessly with bigger host manufacturing and distribution systems.
Remember, this is 1985.
We wanted our product to be capable of solving / improving as many applications as possible - it wasn’t what it was, but what it could do.
Suffice to say, it was a hit in Oz and beyond.
In the early days though, it was tough going. Back then, being a locally made product up against the world’s best was akin to women in the workforce - you had to be twice as good to be considered the same.
We set up tailored simulations of how it could work for individual companies on what was then state of the art - a Compaq ‘portable’ PC, known as a luggable. Prospects would sit gazing at the screen, seeing how it could work for them - feature, function, benefit.
Because funds were short, we started by demonstrating it to what we considered to be the most obvious applications. We made sure our early installations worked a treat and used them as reference points to sell to others. We got into one industry player, and soon others were beating a path to our door.
You might say why is he rabbiting on about this?
Well - I look at what our battler’s doing, and see many parallels with what we did.
Have faith Coppers, nirvana is fast approaching.

Expand

Love it, I have my eye on a boat called Nirvana too. Fingers crossed

BRN Price at posting: 59.8¢ Sentiment: Buy Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PYC

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

AZY

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

MM1

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

There are more pages in this discussion • 94 more messages in this thread...

First 418 Last

Add BRN (ASX) to my watchlist

(20min delay)
Last 20.0¢		Change 0.000(0.00%)		Mkt cap ! $357.2M

Open	High	Low	Value	Volume
20.0¢	20.5¢	19.3¢	$1.097M	5.558M

Buyers (Bids)

No.	Vol.	Price($)
8	86751	20.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	831750	21

View Market Depth

No.	Vol.	Price($)
19	376217	0.200
18	1061406	0.195
67	2258621	0.190
30	1328141	0.185
55	1729425	0.180

Price($)	Vol.	No.
0.205	732266	23
0.210	1131127	17
0.215	446219	14
0.220	817003	22
0.225	590337	16

Last trade - 12.10pm 10/07/2024 (20 minute delay)

BRN (ASX) Chart

South Korea, Samsung, Hyundai + Neuromorphic Chips, page-418

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

South Korea, Samsung, Hyundai + Neuromorphic Chips, page-418

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

PYC commences new study on drug for eye condition Retinitis Pigmentosa type 11

Antipa's Minyari Dome reveals gold up to 24g/t through drilling at key prospect

Midas logs 17 spodumene pegmatite targets over 4km at Aylmer Project in Canada but drills while off

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News